newsfilter
← Latest News
PR Newswire·

Akcea Reports Financial Results and Highlights for Second Quarter 2020

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing...